Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Jiaerke Pharmaceuticals Group is a prominent Chinese pharmaceutical enterprise specializing in the research, development, and large-scale production of steroidal hormone active pharmaceutical ingredients (APIs) and their intermediates. Headquartered in Changzhou, the company maintains a comprehensive manufacturing infrastructure that includes advanced fermentation and chemical synthesis capabilities. Their extensive product portfolio features key corticosteroids such as dexamethasone, betamethasone, prednisone, and hydrocortisone, as well as diuretics like spironolactone. Jiaerke is a major global supplier, holding numerous international certifications including US FDA inspections and European CEPs. The group is recognized for its vertically integrated production chain, ensuring high quality and consistency for pharmaceutical formulators worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Jiaerke Pharmaceuticals Group.